United States · FDA National Drug Code directory
Apretude
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 49702-280_cedc4b34-5c83-4d5f-a47f-7d5e93f71459
- Product NDC
- 49702-280
- Form
- KIT
- Composition / generic term
- Cabotegravir
- Labeler
- ViiV Healthcare Company
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240331
- Source listing expiry
- 20261231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 1 KIT in 1 CARTON (49702-280-63) * 3 mL in 1 VIAL (49702-238-61) · 49702-280-63
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →